GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹9,295 Cr | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr | ₹7,360 Cr |
What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹9,295 Cr |
| Mar2024 | ₹7,428 Cr |
| Mar2023 | ₹8,424 Cr |
| Mar2022 | ₹8,282 Cr |
| Mar2021 | ₹7,360 Cr |
How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,295 Cr | 25.14 | |
| Mar2024 | ₹7,428 Cr | -11.82 | |
| Mar2023 | ₹8,424 Cr | 1.71 | |
| Mar2022 | ₹8,282 Cr | 12.54 | |
| Mar2021 | ₹7,360 Cr | - | |
Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹60,506.5 Cr | 1.6% | -6.6% | 43.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,785.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,242.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,058.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,180.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,149.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.6% |
-6.6% |
43.9% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses